股票/基金 实时行情 股吧

简称:千金药业 代码:600479


会计年度:2013-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合并抵销-33,523,063.73-27,818,144.24-5,704,919.4917.02
其他62,557,192.4334,968,311.4427,588,880.9944.10
药品批发零售735,992,502.96599,044,826.75136,947,676.2118.61
药品生产1,194,946,195.35399,157,032.22795,789,163.1366.60

会计年度:2013-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合并抵销11,995,134.0010,607,181.001,387,952.0011.57
其他29,275,718.0017,479,617.0011,796,101.0040.29
药品批发零售315,116,025.00257,725,133.0057,390,892.0018.21
药品生产520,868,080.00185,910,895.00334,957,185.0064.31

会计年度:2012-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合并抵销37,847,776.0037,038,557.00809,219.002.14
合计1,573,262,298.00785,064,409.00788,197,888.0050.10
其他54,588,975.0029,498,342.0025,090,634.0045.96
药品批发零售562,051,356.00436,573,558.00125,477,798.0022.32
药品生产994,469,742.00356,031,067.00638,438,675.0064.20

会计年度:2012-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合并抵销32,743,222.0033,718,781.00-975,559.00-2.98
其他22,654,778.0012,460,042.0010,194,736.0045.00
药品批发零售295,370,082.00243,634,536.0051,735,545.0017.52
药品生产398,172,503.00117,891,157.00280,281,345.0070.39

会计年度:2011-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合并抵销-69,138,211.00-68,761,494.00-376,718.00-0.54
其他45,153,225.0025,267,930.0019,885,295.0044.04
药品批发零售451,758,205.00365,929,931.0085,828,273.0019.00
药品生产817,807,115.00280,662,720.00537,144,395.0065.68

    4/8 转到